My little one was one of the very last participants in a research study on mB12 that should be published later on this year. The professor who is the lead researcher told me that based on the preliminary results, they saw about a 1/3, 1/3, 1/3 split between big gains, mild gains or mixed results (gains but major side effects), and no results. We saw a mild acceleration of the rate of improvement.